The FDA and Prescription Pancreatic Enzyme Product Cost

被引:7
作者
Gardner, Timothy B. [1 ]
Munson, Jeffrey C. [1 ]
Morden, Nancy E. [1 ]
机构
[1] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA
关键词
D O I
10.1038/ajg.2013.430
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:624 / 625
页数:2
相关论文
共 5 条
[1]  
Food and Drug Administration, RUL HIST OTC EX PANC
[2]  
Food and Drug Administration, UDP QUEST ANSW HEALT
[3]   Pancreatic Enzyme Products: Digesting the Changes [J].
Giuliano, Christopher A. ;
Dehoorne-Smith, Michelle L. ;
Kale-Pradhan, Pramodini B. .
ANNALS OF PHARMACOTHERAPY, 2011, 45 (05) :658-666
[4]   TREATMENT FAILURE AFTER SUBSTITUTION OF GENERIC PANCRELIPASE CAPSULES - CORRELATION WITH INVITRO LIPASE ACTIVITY [J].
HENDELES, L ;
DORF, A ;
STECENKO, A ;
WEINBERGER, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (18) :2459-2461
[5]   Incentives for Drug Development - The Curious Case of Colchicine [J].
Kesselheim, Aaron S. ;
Solomon, Daniel H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (22) :2045-2047